Back to results
US 2023/0142546 A1Published application
Radiopharmaceuticals and composition for thrombus imaging
AssigneesThe Asan Foundation, University of Ulsan Foundation for Industry Cooperation
InventorsSang Ju LEE, Seung Jun OH, Jae-Seung KIM, Dae Hyuk MOON, Sun Young CHAE
Life of this patent
Estimating the term…
Abstract
A compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof: where R1 is a chelating agent labeled with a metallic radioisotope. A thrombus imaging composition including the compound or the pharmaceutically acceptable salt thereof labeled with a metallic radioisotope as an active ingredient.
Claims20
A compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof:
- wherein in Formula 1,
- R1 is selected from the group consisting of
- L is a direct bond, —(CH2)n-NHCO—(CH2)m-, or —((CH2)2O)x-(CH2)n-NHCO—(CH2)m-, and n, m and x are each independently an integer from 0 to 3.
16-17. (canceled)
19-20. (canceled)
Dependencies are inferred from the claim text.